Amyloid-beta: a crucial factor in Alzheimer's disease - PubMed (original) (raw)

Review

Amyloid-beta: a crucial factor in Alzheimer's disease

Saeed Sadigh-Eteghad et al. Med Princ Pract. 2015.

Abstract

Alzheimer's disease (AD) is the most prevalent form of dementia which affects people older than 60 years of age. In AD, the dysregulation of the amyloid-beta (Aβ) level leads to the appearance of senile plaques which contain Aβ depositions. Aβ is a complex biological molecule which interacts with many types of receptors and/or forms insoluble assemblies and, eventually, its nonphysiological depositions alternate with the normal neuronal conditions. In this situation, AD signs appear and the patients experience marked cognitional disabilities. In general, intellect, social skills, personality, and memory are influenced by this disease and, in the long run, it leads to a reduction in quality of life and life expectancy. Due to the pivotal role of Aβ in the pathobiology of AD, a great deal of effort has been made to reveal its exact role in neuronal dysfunctions and to finding efficacious therapeutic strategies against its adverse neuronal outcomes. Hence, the determination of its different molecular assemblies and the mechanisms underlying its pathological effects are of interest. In the present paper, some of the well-established structural forms of Aβ, its interactions with various receptors and possible molecular and cellular mechanisms underlying its neurotoxicity are discussed. In addition, several Aβ-based rodent models of AD are reviewed.

© 2014 S. Karger AG, Basel.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

The 3 major features of AD within the neuronal system. a Cleavage of APP, and formation and accumulation of extraneuronal Aβ. b Formation and deposition of intraneuronal NFTs. c Synaptic dysfunction due to Aβ accumulation and its interaction with receptors. AICD = APP intracellular domain.

Fig. 2

Fig. 2

Interrelationship between Aβ and NFT formation.

Similar articles

Cited by

References

    1. Koudinov AR, Berezov TT. Alzheimer's amyloid-beta (Aβ) is an essential synaptic protein, not neurotoxic junk. Acta Neurobiol Exp. 2004;64:71–79. - PubMed
    1. Carlo MD. Simple model systems: a challenge for Alzheimer's disease. Immun Ageing. 2012;9:3. - PMC - PubMed
    1. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11:111–128. - PMC - PubMed
    1. Anstey KJ, Cherbuin N, Herath PM, et al. A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI. PLoS One. 2014;9:e86141. - PMC - PubMed
    1. Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur J Nucl Med Mol Imaging. 2007;35:46–50. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources